$EOLS

Evolus, Inc.

$6.74
+0.11 (+1.66%) Today

About Evolus, Inc.

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

CEO
Mr. David Moatazedi
Employees
350
Headquarters
Newport Beach, CA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Website
evolus.com

Key stats

Market Cap
$443.86M
P/E Ratio
Avg Volume (3M)
857.14K
EPS
$-0.66
Day's Range
$6.67 – $7.00

Fundamentals as of Jun 18, 2026